Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk-adapted HLA delisting and imlifidase-enabled deceased-donor kidney transplantation in highly sensitized kidney transplant candidates: a German expert consensus report.

Frontiers in immunology·2026
Same author

Sex-based survival disparities persist in liver transplantation: MELD 3.0 fails to improve survival for waitlisted women.

Frontiers in transplantation·2026
Same author

Impact of older donor age in kidney transplants in a biopsy-based observational study.

JCI insight·2026
Same author

Comparison of the Prognostic Value of Three Different Single HLA Based Antibody Detection Assays.

HLA·2026
Same author

Corrigendum to "Improving the histologic detection of donor-specific antibody-negative antibody-mediated rejection in kidney transplants" [American Journal of Transplantation Volume 26, Issue 1, January 2026, Pages 117-130].

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same author

Recipient Social Determinants and Geographic Access in DCD Liver Transplantation: Early Lessons During the Perfusion era.

Transplantation·2026

Related Experiment Video

Updated: May 29, 2026

In Vivo, Percutaneous, Needle Based, Optical Coherence Tomography of Renal Masses
09:31

In Vivo, Percutaneous, Needle Based, Optical Coherence Tomography of Renal Masses

Published on: March 30, 2015

A molecular classifier for predicting future graft loss in late kidney transplant biopsies.

Gunilla Einecke1, Jeff Reeve, Banu Sis

  • 1Alberta Transplant Applied Genomics Centre, University of Alberta, Edmonton, Alberta, Canada.

The Journal of Clinical Investigation
|May 27, 2010
PubMed
Summary
This summary is machine-generated.

A new molecular risk score can predict kidney transplant failure by analyzing gene expression in biopsies. This score identifies patients at high risk for graft loss, offering a superior method to current assessments.

More Related Videos

Using a Chemical Biopsy for Graft Quality Assessment
05:00

Using a Chemical Biopsy for Graft Quality Assessment

Published on: June 17, 2020

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis
09:16

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis

Published on: June 18, 2020

Related Experiment Videos

Last Updated: May 29, 2026

In Vivo, Percutaneous, Needle Based, Optical Coherence Tomography of Renal Masses
09:31

In Vivo, Percutaneous, Needle Based, Optical Coherence Tomography of Renal Masses

Published on: March 30, 2015

Using a Chemical Biopsy for Graft Quality Assessment
05:00

Using a Chemical Biopsy for Graft Quality Assessment

Published on: June 17, 2020

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis
09:16

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis

Published on: June 18, 2020

Area of Science:

  • Nephrology
  • Molecular Biology
  • Transplantation Immunology

Background:

  • Kidney transplant recipients with late-onset renal dysfunction or proteinuria face high risks of graft failure.
  • Current "for-cause" biopsies offer limited predictive value for long-term organ failure.
  • Identifying molecular markers is crucial for predicting kidney allograft loss.

Purpose of the Study:

  • To develop and validate a molecular classifier for predicting graft loss in kidney transplant recipients.
  • To identify genes and molecular pathways associated with kidney allograft failure.
  • To assess the prognostic value of a molecular risk score compared to clinical and histological parameters.

Main Methods:

  • Microarray analysis of gene expression in 105 "for-cause" kidney transplant biopsies (1-31 years post-transplant).
  • Supervised principal components analysis to derive a molecular classifier for graft loss prediction.
  • Correlation of the molecular risk score with histological findings (fibrosis, atrophy, inflammation) and clinical parameters (eGFR, proteinuria).
  • Multivariate analysis and validation in an independent dataset.

Main Results:

  • A molecular classifier predicting graft loss was successfully derived from gene expression data.
  • Genes associated with graft failure related to tissue injury, dedifferentiation, matrix remodeling, and TGF-beta signaling.
  • The molecular risk score correlated significantly with interstitial fibrosis, tubular atrophy, tubulitis, inflammation, proteinuria, and GFR.
  • In multivariate analysis, the molecular risk score, peritubular capillary changes, arteriolar hyalinosis, and proteinuria were independent predictors of graft loss.
  • The molecular risk score was the sole independent predictor of graft loss in the validation set.

Conclusions:

  • A novel molecular risk score accurately predicts kidney allograft failure.
  • This score reflects active injury and outperforms traditional markers like scarring or function.
  • The molecular risk score offers a superior prognostic tool for managing kidney transplant recipients.